Related Experiment Video

Updated: Mar 11, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Next-Generation Sequencing of Lung Cancers: Lessons Learned and Future Directions

Siddhartha Devarakonda1, Ashiq Masood2, Ramaswamy Govindan3

  • 1Division of Oncology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO 63110, USA.

Hematology/Oncology Clinics of North America
|December 4, 2016
PubMed

Insights

Genomic characterization of lung cancer reveals new treatment strategies. Understanding these genetic alterations is key to improving outcomes for many lung cancer patients.

Area of Science:

  • Oncology
  • Genomics
  • Translational Medicine

Background:

  • Metastatic non-small cell lung cancer (NSCLC) outcomes have improved with targeted therapies and immune checkpoint inhibitors.
  • However, a significant majority of lung cancer patients still face poor prognoses.
  • Comprehensive genomic characterization offers a pathway to transform lung cancer care.

Purpose of the Study:

  • To review recent large-scale lung cancer genome sequencing studies.
  • To discuss the diagnostic, prognostic, and therapeutic implications of identified genomic alterations.
  • To highlight the potential for novel treatment strategy development.

Main Methods:

  • Review of recent literature on lung cancer genome sequencing.
  • Analysis of findings from studies sequencing a large number of lung cancer samples.
  • Synthesis of diagnostic, prognostic, and therapeutic relevance of genomic alterations.

Main Results:

  • Recent studies have identified numerous genomic alterations across lung cancer subtypes.
  • These findings have significant diagnostic and prognostic value.
  • Genomic insights are crucial for developing novel targeted therapies.

Conclusions:

  • Comprehensive genomic characterization is transforming lung cancer diagnosis and treatment.
  • Understanding lung cancer genomics is essential for improving patient outcomes.
  • Further research into genomic alterations will facilitate the development of more effective therapies.
Keywords:
Lung cancerSequencingTreatment

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

493
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.2K

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
100.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K